Josh Disbrow, CEO, AYTU, calls refers to the test as "a game-changer". AYTU Bioscience partnered with a Hong-Kong based manufacturer to produce a test kit that takes anywhere between two to ten minutes to provide results. But it awaits approval from the Food and Drug Administration (FDA) for public use.
"Very few tests have been FDA-approved despite the big need. Tests are getting approved but rapid point-of-care tests have not yet been approved. So if this can get approved, it would be among the first, if not the first," said Disbrow.
|